Mohr P - Search Results

1

Schätzung der Prävalenz und Inzidenz von Hautkrebs in Deutschland.

Krensel M, Petersen J, Mohr P, Weishaupt C, Augustin J, Schäfer I. Krensel M, et al. Among authors: mohr p. J Dtsch Dermatol Ges. 2019 Dec;17(12):1239-1250. doi: 10.1111/ddg.14002_g. J Dtsch Dermatol Ges. 2019. PMID: 31885173 German.

2

Gebrauch von Komplementärmedizin bei Patienten mit metastasierendem Melanom unter Therapie mit Ipilimumab innerhalb einer klinischen Studie.

Huebner J, Mohr P, Simon JC, Fluck M, Berking C, Zimmer L, Loquai C. Huebner J, et al. Among authors: mohr p. J Dtsch Dermatol Ges. 2016 May;14(5):508-13. doi: 10.1111/ddg.12750_g. J Dtsch Dermatol Ges. 2016. PMID: 27119473

3

Immune checkpoint inhibitors: a milestone in the treatment of melanoma.

Wilden SM, Lang BM, Mohr P, Grabbe S. Wilden SM, et al. Among authors: mohr p. J Dtsch Dermatol Ges. 2016 Jul;14(7):685-95. doi: 10.1111/ddg.13012. J Dtsch Dermatol Ges. 2016. PMID: 27373242 Review.

4

Checkpoint-Inhibitoren in der Immuntherapie: Ein Meilenstein in der Behandlung des malignen Melanoms.

Wilden SM, Lang BM, Mohr P, Grabbe S. Wilden SM, et al. Among authors: mohr p. J Dtsch Dermatol Ges. 2016 Jul;14(7):685-97. doi: 10.1111/ddg.13012_g. J Dtsch Dermatol Ges. 2016. PMID: 27373243 Review.

5

Association of atopy and tentative diagnosis of skin cancer - results from occupational skin cancer screenings.

Schäfer I, Mohr P, Zander N, Fölster-Holst R, Augustin M. Schäfer I, et al. Among authors: mohr p. J Eur Acad Dermatol Venereol. 2017 Dec;31(12):2083-2087. doi: 10.1111/jdv.14456. Epub 2017 Aug 3. J Eur Acad Dermatol Venereol. 2017. PMID: 28681396

6

Advanced cutaneous squamous cell carcinoma: A retrospective analysis of patient profiles and treatment patterns-Results of a non-interventional study of the DeCOG.

Hillen U, Leiter U, Haase S, Kaufmann R, Becker J, Gutzmer R, Terheyden P, Krause-Bergmann A, Schulze HJ, Hassel J, Lahner N, Wollina U, Ziller F, Utikal J, Hafner C, Ulrich J, Machens HG, Weishaupt C, Hauschild A, Mohr P, Pföhler C, Maurer J, Wolff P, Windemuth-Kieselbach C, Schadendorf D, Livingstone E; Dermatologic Cooperative Oncology Group (DeCOG). Hillen U, et al. Among authors: mohr p. Eur J Cancer. 2018 Jun;96:34-43. doi: 10.1016/j.ejca.2018.01.075. Epub 2018 Apr 14. Eur J Cancer. 2018. PMID: 29665511

7

Decreasing sunbed use in the German population between 2001 and 2015: survey in 155 679 working persons.

Augustin M, Schäfer I, Krensel M, Reusch M, Mohr P, Greinert R, John SM, Zander N. Augustin M, et al. Among authors: mohr p. J Eur Acad Dermatol Venereol. 2019 Mar;33(3):541-545. doi: 10.1111/jdv.15309. Epub 2019 Mar 4. J Eur Acad Dermatol Venereol. 2019. PMID: 30408254

8

Real-World Use of Talimogene Laherparepvec in German Patients with Stage IIIB to IVM1a Melanoma: A Retrospective Chart Review and Physician Survey.

Mohr P, Haferkamp S, Pinter A, Weishaupt C, Huber MA, Downey G, Öhrling K, Loquai C, Louie KS. Mohr P, et al. Adv Ther. 2019 Jan;36(1):101-117. doi: 10.1007/s12325-018-0850-6. Epub 2018 Dec 7. Adv Ther. 2019. PMID: 30536143 Free PMC article.

9

S1-Leitlinie Dermatofibrosarcoma protuberans (DFSP) - Update 2018.

Ugurel S, Kortmann RD, Mohr P, Mentzel T, Garbe C, Breuninger H, Bauer S, Grabbe S. Ugurel S, et al. Among authors: mohr p. J Dtsch Dermatol Ges. 2019 Jun;17(6):663-668. doi: 10.1111/ddg.13849_g. J Dtsch Dermatol Ges. 2019. PMID: 31241846

10

[Social rights claims for malignant melanoma patients : Providing patient information in German dermatological practices].

Zander N, Krensel M, Schäfer I, Weyergraf A, Mohr P, Strömer K, Augustin M. Zander N, et al. Among authors: mohr p. Hautarzt. 2019 Oct;70(10):804-810. doi: 10.1007/s00105-019-4448-y. Hautarzt. 2019. PMID: 31267179 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

571 results

Search Page